One Dr's comments on Besremi approval

[EPguy]

Nothing new for most of us here, but nice to see recent good words from a member of MD Anderson Cancer Center on what many of us are now taking.

curetoday.com/view/fda-s-ap...

Key feature vs PEG is the longer dosing interval, although many members here seem to have multi week intervals on PEG also after time.

Encouraging words:

<<Pemmaraju noted that the long-term findings demonstrate that Besremi is very safe and well tolerated.

“I think the strength of this data set is that you have such a long follow-up,” he said. “It’s very comforting to see that. You don’t always have that long-term follow-up before you have a drug in the clinic.”>>

He also notes what we are doing:

<<even post-approval, all of us need to watch out for toxicity (and) side effects>>